ALMDP.PA
Price:
$0.35
Market Cap:
$1.80M
Medesis Pharma S.A., a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. Its products include NanoLithium (NP03), a clinical stage development product for the treatment of Alzheimer's disease; NanosiRNA DH for the treatment of Huntington's Disease; NU01 Plutonium and NU02 Cesium decorporation products for nuclear decorporation; a radioprotection drug to treat people irradiated following a civil or military nuclear accident (NP02 NanoManganese); NanosiRNA COVID-19, an antiviral treatment solution for viral diseases; and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for ...[Read more]
Industry
Biotechnology
IPO Date
2021-02-12
Stock Exchange
PAR
Ticker
ALMDP.PA
According to Medesis Pharma S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -0.59. This represents a change of -48.56% compared to the average of -1.15 of the last 4 quarters.
The mean historical PE Ratio of Medesis Pharma S.A. over the last ten years is -17.58. The current -0.59 PE Ratio has changed 237.36% with respect to the historical average. Over the past ten years (40 quarters), ALMDP.PA's PE Ratio was at its highest in in the December 2023 quarter at -0.46. The PE Ratio was at its lowest in in the June 2020 quarter at -22.70.
Average
-17.58
Median
-12.63
Minimum
-44.43
Maximum
-1.09
Discovering the peaks and valleys of Medesis Pharma S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 165.34%
Maximum Annual PE Ratio = -1.09
Minimum Annual Increase = -80.85%
Minimum Annual PE Ratio = -44.43
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -1.09 | -65.54% |
| 2022 | -3.16 | -62.92% |
| 2021 | -8.51 | -80.85% |
| 2020 | -44.43 | 165.34% |
| 2019 | -16.74 | -46.97% |
The current PE Ratio of Medesis Pharma S.A. (ALMDP.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.25
5-year avg
-14.79
10-year avg
-17.58
Medesis Pharma S.A.’s PE Ratio is less than Deinove S.A. (-0.11), less than PHAXIAM Therapeutics S.A. (-0.02), greater than Pixium Vision S.A. (-1.92), less than Pharnext S.A. (-0.00), less than Neovacs S.A. (-0.00), less than Acticor Biotech SAS (-0.16), less than Hybrigenics S.A. (-0.21), greater than Gour Medical S.A. (-1.67), less than Genomic Vision S.A. (-0.04), less than Lysogene S.A. (-0.34),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.11 | $1.13M | |
| -0.02 | $1.01M | |
| -1.92 | $1.16M | |
| -0.00 | $1.19K | |
| -0.00 | $6.58K | |
| -0.16 | $3.94M | |
| -0.21 | $3.95M | |
| -1.67 | $536.27K | |
| -0.04 | $693.19K | |
| -0.34 | $4.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medesis Pharma S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medesis Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Medesis Pharma S.A.'s PE Ratio?
How is the PE Ratio calculated for Medesis Pharma S.A. (ALMDP.PA)?
What is the highest PE Ratio for Medesis Pharma S.A. (ALMDP.PA)?
What is the 3-year average PE Ratio for Medesis Pharma S.A. (ALMDP.PA)?
What is the 5-year average PE Ratio for Medesis Pharma S.A. (ALMDP.PA)?
How does the current PE Ratio for Medesis Pharma S.A. (ALMDP.PA) compare to its historical average?